Kikkawa F - Search Results

1

Hematopoietic lineage cell-specific protein 1 immunoreactivity indicates an increased risk of poor overall survival in patients with ovarian carcinoma.

Liu W, Kajiyama H, Shibata K, Koya Y, Senga T, Kikkawa F. Liu W, et al. Among authors: kikkawa f. Oncol Lett. 2018 Jun;15(6):9406-9412. doi: 10.3892/ol.2018.8493. Epub 2018 Apr 13. Oncol Lett. 2018. PMID: 29805664 Free PMC article.

2

Accumulation of cis-diamminedichloroplatinum (II) and its analogues in sensitive and resistant human ovarian carcinoma cells.

Misawa T, Kikkawa F, Oguchi H, Morikawa Y, Kawai M, Maeda O, Iwata M, Kano T, Furuhashi Y, Tomada Y. Misawa T, et al. Among authors: kikkawa f. Oncology. 1992;49(3):173-9. doi: 10.1159/000227034. Oncology. 1992. PMID: 1495742

3

Clinical value of CA125, CA19-9, CEA, CA72-4, and TPA in borderline ovarian tumor.

Tamakoshi K, Kikkawa F, Shibata K, Tomoda K, Obata NH, Wakahara F, Tokuhashi Y, Ishikawa H, Kawai M, Tomoda Y. Tamakoshi K, et al. Among authors: kikkawa f. Gynecol Oncol. 1996 Jul;62(1):67-72. doi: 10.1006/gyno.1996.0191. Gynecol Oncol. 1996. PMID: 8690294

4

Mucinous carcinoma of the ovary. Clinicopathologic analysis.

Kikkawa F, Kawai M, Tamakoshi K, Suganuma N, Nakashima N, Furuhashi Y, Kuzuya K, Hattori S, Arii Y, Tomoda Y. Kikkawa F, et al. Oncology. 1996 Jul-Aug;53(4):303-7. doi: 10.1159/000227577. Oncology. 1996. PMID: 8692534

5

Combination effect of anti-Fas antibody and chemotherapeutic drugs in ovarian cancer cells in vitro.

Wakahara Y, Nawa A, Okamoto T, Hayakawa A, Kikkawa F, Suganama N, Wakahara F, Tomoda Y. Wakahara Y, et al. Among authors: kikkawa f. Oncology. 1997 Jan-Feb;54(1):48-54. doi: 10.1159/000227661. Oncology. 1997. PMID: 8978593

6

Effects of interleukin-6 on in vitro cell attachment, migration and invasion of human ovarian carcinoma.

Obata NH, Tamakoshi K, Shibata K, Kikkawa F, Tomoda Y. Obata NH, et al. Among authors: kikkawa f. Anticancer Res. 1997 Jan-Feb;17(1A):337-42. Anticancer Res. 1997. PMID: 9066674

7

A randomized trial of cisplatin, vinblastine, and bleomycin versus cyclophosphamide, aclacinomycin, and cisplatin in epithelial ovarian cancer.

Tokuhashi Y, Kikkawa F, Tamakoshi K, Suganuma N, Kuzuya K, Arii Y, Kawai M, Hattori S, Kobayashi I, Furuhashi Y, Nakashima N, Tomoda Y. Tokuhashi Y, et al. Among authors: kikkawa f. Oncology. 1997 Jul-Aug;54(4):281-6. doi: 10.1159/000227704. Oncology. 1997. PMID: 9216851 Clinical Trial.

8

Increased matrix metalloproteinase-9 activity in human ovarian cancer cells cultured with conditioned medium from human peritoneal tissue.

Shibata K, Kikkawa F, Nawa A, Tamakoshi K, Suganuma N, Tomoda Y. Shibata K, et al. Among authors: kikkawa f. Clin Exp Metastasis. 1997 Nov;15(6):612-9. doi: 10.1023/a:1018495414975. Clin Exp Metastasis. 1997. PMID: 9344045

9

Fibronectin secretion from human peritoneal tissue induces Mr 92,000 type IV collagenase expression and invasion in ovarian cancer cell lines.

Shibata K, Kikkawa F, Nawa A, Suganuma N, Hamaguchi M. Shibata K, et al. Among authors: kikkawa f. Cancer Res. 1997 Dec 1;57(23):5416-20. Cancer Res. 1997. PMID: 9393769

10

Both focal adhesion kinase and c-Ras are required for the enhanced matrix metalloproteinase 9 secretion by fibronectin in ovarian cancer cells.

Shibata K, Kikkawa F, Nawa A, Thant AA, Naruse K, Mizutani S, Hamaguchi M. Shibata K, et al. Among authors: kikkawa f. Cancer Res. 1998 Mar 1;58(5):900-3. Cancer Res. 1998. PMID: 9500447

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

561 results

Search Page

Filters